Memorandum by Dr Sarah MacKenzie Ross
MA, MPhil, C.Psychol, DPsychol, AFBPsS
RE: AIR
TRAVEL AND
HEALTHSUBMISSION
OF NEW
EVIDENCE
1.1 I am a Consultant Clinical Neuropsychologist
based at University College London and I would like to submit
new evidence that has been produced since 2000 on the health effects
of air travel. In particular, health effects associated with exposure
to engine oil fumes in the aircraft cabin.
1.2. Throughout 2005 and 2006 I examined
a number of pilots who complained of ill health following reported
exposure to contaminated air on commercial aircraft. I prepared
a report detailing my findings for the Committee on Toxicity of
Chemicals in Food, Consumer Products and the Environment, entitled
Cognitive function following reported exposure to contaminated
air on commercial aircraft: An audit of 27 airline pilots seen
for clinical purposes.
SUMMARY OF
MY REPORT[1]
2.1 I identified a profile of cognitive
deficits in pilots which involves under functioning on tests of
working memory, verbal memory, attention, mental flexibility and
information processing speed. These deficits can not be attributed
to factors such as mood disorder, anxiety disorder, malingering
or chance.
2.2 My findings are of obvious concern as
they pose a risk to flight safety. A pilot's job involves complex
three dimensional thought processing and a need to accurately
interpret, shift attention between and respond to changing information
presented to them by flight instruments, navigation systems and
air traffic controllers.
2.3 The pilots I examined were tested during
the day and were asked to perform to the best of their ability,
yet deficits were identified. These deficits may be magnified
under particular working conditions, such as when a pilot is fatigued
after a long shift at work or under stress in a complex emergency
situation.
2.4 My report has been considered by the
Committee on Toxicity (COT), and they arranged for it to be peer-reviewed
by an independent expert and Professor of Neuropsychology who
concluded that my study was well designed, had been conducted
with an appropriately high level of expertise; and that the deficits/abnormalities
identified were striking and of sufficient severity to cause concern
about the functioning of implicated aircrew.
SUMMARY OF
A SCIENTIFIC
PAPER DESCRIBING
A SINGLE
CASE STUDY,
RECENTLY PUBLISHED
IN THE
JOURNAL OF
OCCUPATIONAL HEALTH
AND SAFETY,
AUSTRALIA AND
NEW ZEALAND
IN 2006[2]
3.1 In this paper we conclude that: Potential
contamination of aircraft cabin air by engine oil fumes is a serious
aviation safety concern for both crew and passengers and further
research is needed to determine the potential toxicity of pyrolised
engine oil under aviation conditions (ie at altitude, in a reduced
oxygen environment, after being subjected to extreme temperature).
The medical profession should develop internationally agreed medical
protocols for the evaluation and treatment of affected individuals.
Aircrew who report ill health following exposure to contaminated
air should be referred for further investigations, including psychology,
neurology, neurophysiology, neuroimaging and respiratory. Diagnoses
such as "industrial hysteria" and "psychosomatic
disorder" are unhelpful and misleading and should only be
made if there is clear evidence that psychological factors are
involved in the aetiology of a patient's complaints. Absence of
underlying pathology following medical examination is not proof
of an actual non organic condition, particularly in the context
of a history that might reasonably account for the symptoms.
FURTHER RESEARCH
HAS BEEN
PUBLISHED SINCE
2000 THAT MAY
INVALIDATE THE
CONCLUSIONS DRAWN
BY THE
COMMITTEE IN
2000
4.1. For example, the Committee focused
heavily on the presence of one chemical isomer of Tricresyl phosphate,
namely, Tri-orth-cresyl phosphate (TOCP) to ascertain the potential
risk to passengers and crews of developing ill health following
exposure to engine oil fumes. The Committee concluded that the
low levels of TOCP that might be found following an oil leak would
not pose a "significant risk to the health of passengers
and crew".
4.2 However, it is important to consider
(a) other more toxic TCP isomers which are present in much higher
concentrations than TOCP and have higher toxicity;[3]
and the combined, synergistic effects of all of the chemicals
present in engine oil (see below).
4.3 Recent research has shown that adverse
effects may be caused by impurities and/or other constituents
of the formulated products (eg solvents), as opposed to the active
ingredients; and there may be synergistic effects of chemical
combinations.[4]
Combined exposure to other chemicals which cause oxidative stress
can decrease the level required to produce neuronal damage following
exposure to organophosphates.[5]
Animal studies have shown that when two chemicals are combined
(eg an OP plus DEET) severe neurotoxic effects were seen in the
peripheral and central nervous system and increased mortality
even though safe levels of each chemical were chosen. In other
words when certain chemicals are combined, even at safe levels,
the end product can be more toxic than what would be predicted
from the known properties of each chemical which makes up the
mixture.[6]
Furthermore, toxicological testing needs to consider health outcomes
other than the extremely rare condition known as OPIDN. Physical,
cognitive and emotional consequences of exposure should be considered
first.[7]
4.4 It is also important to consider the
possibility that genetic differences between individuals may render
some people more susceptible to the toxic effects of certain chemicals
than others. A number of papers have been published since 2000
which find an association between genetically determined polymorphisms
and the development of ill health following exposure to organophosphate
pesticides.[8],
[9],
[10],
[11]
RECOMMENDATIONSGAPS
IN THE
EVIDENCE BASE
5.1 Given the scientific uncertainty regarding
the potential hazards of inhalation of pyrolised engine oil, further
research into the full range of health effects from inhalation
of heated or pyrolised synthetic jet oils is definitely warranted.
This research should consist of:
(a) On board monitoring to determine the
contaminants and level of each contaminant that enters the aircraft.
The Committee recommended in 2000 that airlines carry out cabin
atmosphere sampling (see paragraphs 1.25 and 1.26) and undertake
real time monitoring of air quality (see paragraph 1.43 (c);
(b) An Epidemiological Survey to determine
the incidence and prevalence of ill health in aircrew and any
association there might be with exposure to contaminated air.
A sub-sample of aircrew should also undergo clinical examinations
by a multi-disciplinary group of healthcare professionals to explore
the nature of any symptoms identified in more depth, determine
severity and impact on life, ascertain whether there are subgroups
of people at particular risk (eg the elderly, pregnant women,
children, persons of less than average health). The House of Lords
Science and Technology Select Committee recommended in 2000 that
maximum value should be extracted from the medical records of
aircrew concerning any long-term effects from exposure to the
aircraft cabin environmentsee paragraph 1.43 (f);
(c) A survey needs to be undertaken to determine
whether passengers are affected by exposure to engine oil fumes
on board aircraft;
(d) Toxicological testing needs to be undertaken
that takes account of the potential synergistic effects of the
range of different chemicals found in engine oil; and this research
should consider health outcomes other than OPIDN, such as physical,
cognitive and emotional disorder;
(e) The current edition of the Department
of Health book aimed at professionals should contain information
about the potential health effects of exposure to engine oil fumes;
(f) Whilst this research is being undertaken,
the Government and regulators should re-consider (a) supplying
only fresh air to the flight deck (see paragraph 1.24) and/or
(b) installing filters to minimise the risk to aircrew and passengers
of engine oil fumes.
7 June 2007
References
Haley, R W, Billecke, S, La Du, B N (1999). Association
of low PON1 Type Q (Type A) arylesterase activity with neurologic
symptom complexes in Gulf War veterans. Toxicology and Applied
Pharmacology, 157, 227-233.
Richter R J and Furlong, C E (1999). Determination
of paraoxonase (PON1) status requires more than genotyping.
Pharmacogenetics, 9: 745-753.
1 A report prepared for the Committee on Toxicity of
Chemicals in Food, Consumer Products and the Environment, entitled
Cognitive function following reported exposure to contaminated
air on commercial aircraft: An audit of 27 airline pilots seen
for clinical purposes, by Dr Sarah Mackenzie Ross. Back
2
S J Mackenzie Ross, A C Harper, J Burdon (2006). Ill health following
reported exposure to contaminated air on commercial aircraft:
psychosomatic disorder or neurological injury? The Journal
of Occupational Health and Safety, Australia and New Zealand (22)
521-528. Back
3
C Winder. Hazardous chemicals on jet aircraft: Case study-jet
engine oils. In C Winder ed Proceedings of the BALPA Air Safety
and Cabin Air Quality International Aero Industry Conference,
held at Imperial College, London 20-21 April 2005. Published by
the British Airline Pilots Association (BALPA) and the School
of Safety Science, University of New South Wales, Sydney NSW
2052. Back
4
Karalliedde, LD, Edwards, P and Marrs, TC (2003) Variables influencing
the toxic response to organophosphates in humans, Food and
Chemical Toxicology, 41, 1-13. Back
5
Abou-Donia, M (2005) Organophosphorus ester-induced chronic neurotoxicity,
Archives of Environmental Health, 58(8), 484-497. Back
6
Abou-Donia, M, Wilmarth, K R, Abdel-Rahman, A, Jensen, K F, Oeheme,
F W and Kurt, T L (1996) Increased neurotoxicity following concurrent
exposure to pyridostigmine bromide, DEET, and chlorpyrifos,
Fundamental Applied Toxicology, 34, 201-22; Furlong, presentation
given to DEFRA in 2006. Back
7
S J Mackenzie Ross, J S Clark, V Harrison, K M Abraham (2007).
Cognitive impairment following exposure to organophosphate pesticides:
A pilot study. Journal of Occupational Health and Safety: Australia
and New Zealand (in press, April 2007). Back
8
Cherry, N, Mackness, M, Durrington, P, Povey, A, Dippnall, M,
Smith, T and Mackness, B (2002) Paraoxonase (PON1) polymorphisms
in farmers attributing ill health to sheep dip. The Lancet,
359, 763¸4. Back
9
Mackness, B, Durrington, P, Povey, A, Thomson, S, Dippnall, M,
Mackness, M, Smith, T and Cherry, N (2003) Paraoxonase and susceptibility
to organophosphorus poisoning in farmers dipping sheep. Pharmacogenetics,
13 (2), 81-88. Back
10
Costa, L G, Richter, R J, Li, W F, Cole, T B, Guizzetti, M and
Furlong, C E (2003) Paraoxonase (PON 1) as a biomarker of susceptibility
for organophosphate toxicity. Biomarkers, 8 (1), 1-12. Back
11
Costa, L G, Cole, T B, Jarvik, G P snf Furlong C E (2003) Functional
genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide
sensitivity, cardiovascular disease, and drug metabolism. Annual
Review of Medicine, 54, 371-392. Back
|